dc.contributor.advisor |
Yıldız, Demir Kürşat |
|
dc.contributor.author |
Yılmaz, Cansu Eda |
|
dc.date.accessioned |
2022-03-04T11:35:28Z |
|
dc.date.available |
2022-03-04T11:35:28Z |
|
dc.date.issued |
2017 |
|
dc.identifier.other |
480828 |
|
dc.identifier.uri |
http://dspace.kocaeli.edu.tr:8080/xmlui/handle/11493/13575 |
|
dc.language.iso |
tur |
|
dc.publisher |
Kocaeli Üniversitesi, Tıp Fakültesi |
|
dc.rights |
openAccess |
|
dc.subject |
Asbest |
|
dc.subject |
Asbestos |
|
dc.subject |
Hücre döngüsü |
|
dc.subject |
Cell cycle |
|
dc.subject |
Karsinojenler |
|
dc.subject |
Carcinogens |
|
dc.subject |
Mezotelyoma |
|
dc.subject |
Mesothelioma |
|
dc.subject |
Neoplazmlar |
|
dc.subject |
Neoplasms |
|
dc.subject |
Patoloji |
|
dc.subject |
Pathology |
|
dc.subject |
Prognoz |
|
dc.subject |
Prognosis |
|
dc.subject |
İnhibitör |
|
dc.subject |
Inhibitor |
|
dc.title |
Malign mezotelyoma olguarında hücre döngü inhibitörerinden MDM2,P53 ve P16 belirteçlerinin prognoz üzerine etkisi |
|
dc.title.alternative |
The effect of MDM2, P53 and p16 markers on the prognosis of cell cycle inhibitor in malignant mesothelioma cases |
|
dc.type |
specialtyThesis |
|
dc.contributor.department |
Patoloji Ana Bilim Dalı |
|
dc.identifier.endpage |
60 |
|